Observational studyTherapeutic advances in respiratory disease
Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis.
Sydney Blankenship et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.